ID

39632

Descripción

Safety and Efficacy of ANA598 Administered With Pegylated Interferon and Ribavirin in Genotype-1 Patients With Chronic HCV Infection; ODM derived from: https://clinicaltrials.gov/show/NCT01281423

Link

https://clinicaltrials.gov/show/NCT01281423

Palabras clave

Versiones (1)
  1. 6/2/20 6/2/20 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

6 de febrero de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hepatitis C NCT01281423

Inglés

Eligibility Hepatitis C NCT01281423

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented chronic hepatitis c infection, genotype 1 at screening
Descripción

Chronic Hepatitis C Genotype

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C1533728
treatment-naïve; no prior exposure to pegylated interferon, ribavirin, or experimental hcv therapy
Descripción

Therapy naive | Absence Exposure to PEGINTERFERON | Absence Exposure to Ribavirin | Absence Investigational Therapy Hepatitis C

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0332157
UMLS CUI [2,3]
C0982327
UMLS CUI [3,1]
C0332197
UMLS CUI [3,2]
C0332157
UMLS CUI [3,3]
C0035525
UMLS CUI [4,1]
C0332197
UMLS CUI [4,2]
C0949266
UMLS CUI [4,3]
C0019196
treatment-experienced patients including partial responders, prior relapse, prior viral breakthrough, and null responders; prior treatment with current standard of care (pegylated interferon alfa and ribavirin)
Descripción

Therapeutic procedure Experience | Therapy partial responder | Recurrent disease | Viral Breakthrough | Null responder | Standard of Care Previous | pegylated interferon alfa | Ribavirin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0596545
UMLS CUI [2]
C4285679
UMLS CUI [3]
C0277556
UMLS CUI [4]
C4053869
UMLS CUI [5,1]
C0456148
UMLS CUI [5,2]
C0919876
UMLS CUI [6,1]
C2936643
UMLS CUI [6,2]
C0205156
UMLS CUI [7]
C0907160
UMLS CUI [8]
C0035525
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
female patients who are pregnant or breast feeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
infection with non-genotype 1 hcv
Descripción

Hepatitis C | Exception Hepatitis C virus genotype determination

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019196
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1533728
for treatment-naïve patients: any previous treatment for hcv infection
Descripción

Patients Therapy naive | Prior Therapy Hepatitis C

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0919936
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0019196
for treatment-experienced patients: previous treatment with any direct-acting antivirals for hcv infection
Descripción

Patients Therapeutic procedure Experience | Prior Therapy DIRECT ACTING ANTIVIRALS Hepatitis C

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0596545
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C3653501
UMLS CUI [2,3]
C0019196
known hiv or hbv co-infection
Descripción

HIV coinfection | HBV coinfection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4062778
UMLS CUI [2]
C2242656
any medical contraindications to peg-inf or rbv therapy
Descripción

Medical contraindication PEGINTERFERON | Medical contraindication Ribavirin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0982327
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0035525
history of any other known cause of liver disease
Descripción

Liver disease Cause Other

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0015127
UMLS CUI [1,3]
C0205394
Volver a la parte superior de la página

Similar models

Eligibility Hepatitis C NCT01281423

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Hepatitis C Genotype
Item
documented chronic hepatitis c infection, genotype 1 at screening
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
Therapy naive | Absence Exposure to PEGINTERFERON | Absence Exposure to Ribavirin | Absence Investigational Therapy Hepatitis C
Item
treatment-naïve; no prior exposure to pegylated interferon, ribavirin, or experimental hcv therapy
boolean
C0919936 (UMLS CUI [1])
C0332197 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0982327 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C0332157 (UMLS CUI [3,2])
C0035525 (UMLS CUI [3,3])
C0332197 (UMLS CUI [4,1])
C0949266 (UMLS CUI [4,2])
C0019196 (UMLS CUI [4,3])
Therapeutic procedure Experience | Therapy partial responder | Recurrent disease | Viral Breakthrough | Null responder | Standard of Care Previous | pegylated interferon alfa | Ribavirin
Item
treatment-experienced patients including partial responders, prior relapse, prior viral breakthrough, and null responders; prior treatment with current standard of care (pegylated interferon alfa and ribavirin)
boolean
C0087111 (UMLS CUI [1,1])
C0596545 (UMLS CUI [1,2])
C4285679 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
C4053869 (UMLS CUI [4])
C0456148 (UMLS CUI [5,1])
C0919876 (UMLS CUI [5,2])
C2936643 (UMLS CUI [6,1])
C0205156 (UMLS CUI [6,2])
C0907160 (UMLS CUI [7])
C0035525 (UMLS CUI [8])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
female patients who are pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hepatitis C | Exception Hepatitis C virus genotype determination
Item
infection with non-genotype 1 hcv
boolean
C0019196 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1533728 (UMLS CUI [2,2])
Patients Therapy naive | Prior Therapy Hepatitis C
Item
for treatment-naïve patients: any previous treatment for hcv infection
boolean
C0030705 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
Patients Therapeutic procedure Experience | Prior Therapy DIRECT ACTING ANTIVIRALS Hepatitis C
Item
for treatment-experienced patients: previous treatment with any direct-acting antivirals for hcv infection
boolean
C0030705 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0596545 (UMLS CUI [1,3])
C1514463 (UMLS CUI [2,1])
C3653501 (UMLS CUI [2,2])
C0019196 (UMLS CUI [2,3])
HIV coinfection | HBV coinfection
Item
known hiv or hbv co-infection
boolean
C4062778 (UMLS CUI [1])
C2242656 (UMLS CUI [2])
Medical contraindication PEGINTERFERON | Medical contraindication Ribavirin
Item
any medical contraindications to peg-inf or rbv therapy
boolean
C1301624 (UMLS CUI [1,1])
C0982327 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0035525 (UMLS CUI [2,2])
Liver disease Cause Other
Item
history of any other known cause of liver disease
boolean
C0023895 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial